Saudi Central Bank Purchases 5,059 Shares of HCA Healthcare, Inc. $HCA

Saudi Central Bank boosted its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 85.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,955 shares of the company’s stock after buying an additional 5,059 shares during the quarter. Saudi Central Bank’s holdings in HCA Healthcare were worth $4,271,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Brighton Jones LLC acquired a new position in HCA Healthcare during the fourth quarter worth $1,021,000. NewEdge Advisors LLC boosted its stake in shares of HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC increased its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the last quarter. Jump Financial LLC bought a new position in HCA Healthcare in the second quarter valued at approximately $2,073,000. Finally, Sei Investments Co. raised its stake in shares of HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after purchasing an additional 49,214 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on HCA shares. KeyCorp lowered their target price on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a report on Monday, July 27th. Barclays lowered their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research note on Monday, July 27th. Weiss Ratings cut HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Wells Fargo & Company upped their price objective on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Finally, Truist Financial decreased their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $462.64.

View Our Latest Research Report on HCA

HCA Healthcare Stock Performance

HCA opened at $404.95 on Monday. The stock has a fifty day moving average of $403.35 and a 200-day moving average of $436.82. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The company has a market capitalization of $87.67 billion, a P/E ratio of 13.56, a P/E/G ratio of 1.33 and a beta of 1.10.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the previous year, the company earned $6.84 EPS. The business’s revenue was up 8.7% on a year-over-year basis. On average, equities research analysts predict that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.